{
    "nctId": "NCT02083991",
    "officialTitle": "A Controlled Randomized, Open-label, Multi-centre Study Evaluating if a Steroid-free Immunosuppressive Protocol, Based ATG-induction, Low Tacrolimus-dose and Therapeutic Drug Monitoring of Mycophenolate Mofetil, Reduces the Incidence of New Onset Diabetes After Transplantations, in Comparison With Standard Steroid-based Protocol With Low-dose Tacrolimus.",
    "inclusionCriteria": "* First or second single kidney (cadaveric or living donors) transplant recipients.\n* Considered for a standard immunosuppressive protocol.\n* Must be capable of giving written informed connect for participation in the study for 24 months.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Diabetes mellitus or plasma glucose \\>11,1 at admission.\n* Receiving steroids at the time of transplantation or likely to need steroids after transplantation.\n* Multiorgan transplants and/or previously transplanted with any other organ than kidney.\n* Panel reacting antibodies(PRA) \\>25% in most recent test or considered to be of high risk for rejection which requires an enhanced immunosuppression.\n* Renal transplants from HLA-identical sibling.\n* Hypersensitivity to, or disability to take immunosuppressive drugs.\n* Blood group(ABO)-incompatible transplants.\n* Unlikely to comply with the study requirements.\n* Transplant from donor positive for HIV, HBsAg, Hepatitis C.\n* Female of childbearing potential planing/being pregnant or unwilling to use contraception."
}